113 related articles for article (PubMed ID: 14608138)
1. In-hospital initiation of cardiovascular protective medications for patients undergoing percutaneous coronary intervention: taking advantage of the teachable moment.
Fonarow GC
J Invasive Cardiol; 2003 Nov; 15(11):646-52. PubMed ID: 14608138
[TBL] [Abstract][Full Text] [Related]
2. The role of in-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes.
Fonarow GC
Rev Cardiovasc Med; 2003; 4 Suppl 3():S37-46. PubMed ID: 14564233
[TBL] [Abstract][Full Text] [Related]
3. The role of in-hospital initiation of cardioprotective therapies to improve treatment rates and clinical outcomes.
Fonarow GC
Rev Cardiovasc Med; 2002; 3 Suppl 3():S2-S10. PubMed ID: 12447156
[TBL] [Abstract][Full Text] [Related]
4. Strategies to improve the use of evidence-based heart failure therapies: OPTIMIZE-HF.
Fonarow GC
Rev Cardiovasc Med; 2004; 5 Suppl 1():S45-54. PubMed ID: 15184838
[TBL] [Abstract][Full Text] [Related]
5. Strategies to improve the use of evidence-based heart failure therapies.
Fonarow GC
Rev Cardiovasc Med; 2005; 6 Suppl 2():S32-42. PubMed ID: 15891703
[TBL] [Abstract][Full Text] [Related]
6. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
[TBL] [Abstract][Full Text] [Related]
7. Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.
Fonarow GC; Gheorghiade M; Abraham WT
Am J Cardiol; 2004 Nov; 94(9):1155-60. PubMed ID: 15518610
[TBL] [Abstract][Full Text] [Related]
8. In-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes: the University of California-Los Angeles, Cardiovascular Hospitalization Atherosclerosis Management Program.
Fonarow GC; Gawlinski A; Watson K
Crit Pathw Cardiol; 2003 Jun; 2(2):61-70. PubMed ID: 18340322
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry).
Steinberg BA; Steg PG; Bhatt DL; Fonarow GC; Zeymer U; Cannon CP;
Am J Cardiol; 2007 May; 99(9):1212-5. PubMed ID: 17478144
[TBL] [Abstract][Full Text] [Related]
10. Role of in-hospital initiation of carvedilol to improve treatment rates and clinical outcomes.
Fonarow GC
Am J Cardiol; 2004 May; 93(9A):77B-81B. PubMed ID: 15144944
[TBL] [Abstract][Full Text] [Related]
11. How well are chronic heart failure patients being managed?
Fonarow GC
Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
[TBL] [Abstract][Full Text] [Related]
12. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
[TBL] [Abstract][Full Text] [Related]
13. Application of evidence-based medical therapy is associated with improved outcomes after percutaneous coronary intervention and is a valid quality indicator.
Jaber WA; Lennon RJ; Mathew V; Holmes DR; Lerman A; Rihal CS
J Am Coll Cardiol; 2005 Oct; 46(8):1473-8. PubMed ID: 16226170
[TBL] [Abstract][Full Text] [Related]
14. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
15. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
Motovska Z; Kala P
Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
[TBL] [Abstract][Full Text] [Related]
16. Interventions to improve guideline compliance following coronary artery bypass grafting.
Yam FK; Akers WS; Ferraris VA; Smith K; Ramaiah C; Camp P; Flynn JD
Surgery; 2006 Oct; 140(4):541-7; discussion 547-52. PubMed ID: 17011901
[TBL] [Abstract][Full Text] [Related]
17. Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get With the Guidelines Program.
Brilakis ES; Hernandez AF; Dai D; Peterson ED; Banerjee S; Fonarow GC; Cannon CP; Bhatt DL
Circulation; 2009 Aug; 120(7):560-7. PubMed ID: 19652090
[TBL] [Abstract][Full Text] [Related]
18. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
[TBL] [Abstract][Full Text] [Related]
19. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients.
Yasuda K; Kasuga H; Aoyama T; Takahashi H; Toriyama T; Kawade Y; Iwashima S; Yamada S; Kawahara H; Maruyama S; Yuzawa Y; Ishii H; Murohara T; Matsuo S
J Am Soc Nephrol; 2006 Aug; 17(8):2322-32. PubMed ID: 16837633
[TBL] [Abstract][Full Text] [Related]
20. Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study.
Chocron S; Baillot R; Rouleau JL; Warnica WJ; Block P; Johnstone D; Myers MG; Calciu CD; Nozza A; Martineau P; van Gilst WH;
Eur Heart J; 2008 Mar; 29(5):673-9. PubMed ID: 18285358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
